CD40L-Specific TN3-Derived Scaffolds For The Treatment And Prevention Of Sjogren`s Syndrome
PH12025552334A1Pending Publication Date: 2026-06-29VIELA BIO INC
Patent Information
- Authority / Receiving Office
- PH · PH
- Patent Type
- Applications
- Current Assignee / Owner
- VIELA BIO INC
- Filing Date
- 2025-09-25
- Publication Date
- 2026-06-29
Need to check novelty before this filing date? Find Prior Art
No text content released.